Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on long-acting and intermediate-acting insulin products.

Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on long-acting and intermediate-acting insulin products.

Item
http://www.wikidata.org/entity/Q36085040
Identifying and meeting the challenges of insulin therapy in type 2 diabetes.Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention.Medical expenditures associated with diabetes acute complications in privately insured U.S. youth.Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients.Reduced risk of hypoglycemia with once-daily glargine versus twice-daily NPH and number needed to harm with NPH to demonstrate the risk of one additional hypoglycemic event in type 2 diabetes: Evidence from a long-term controlled trial.The cost-effectiveness of insulin glargine vs. neutral protamine Hagedorn insulin in type 2 diabetes: a focus on health economics.Insulin use in elderly adults: risk of hypoglycemia and strategies for care.Resource utilisation and quality of life following initiation of insulin detemir in patients with type 2 diabetes mellitus.Hypoglycemic potential of current and emerging pharmacotherapies in type 2 diabetes mellitus.Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus.Hypoglycemic events analysis via recurrent time-to-event (HEART) models.Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs.
P2860

Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on long-acting and intermediate-acting insulin products.

Item
http://www.wikidata.org/entity/Q36085040
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Differences in hypoglycemia ev ...... diate-acting insulin products.
@ast
Differences in hypoglycemia ev ...... diate-acting insulin products.
@en
type
label
Differences in hypoglycemia ev ...... diate-acting insulin products.
@ast
Differences in hypoglycemia ev ...... diate-acting insulin products.
@en
prefLabel
Differences in hypoglycemia ev ...... diate-acting insulin products.
@ast
Differences in hypoglycemia ev ...... diate-acting insulin products.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Differences in hypoglycemia ev ...... diate-acting insulin products.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921